Efficacy of Contact Needle Therapy for Chemotherapy-Induced Peripheral Neuropathy
Cancer chemotherapy-induced peripheral neuropathy (CIPN) often results in discontinuation of treatment with potentially useful anticancer drugs and may deteriorate the patient’s quality of life. This study investigated the effect of contact needle therapy (CNT) on CIPN caused by responsible chemothe...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/928129 |
id |
doaj-7ea3d5866df04bde97a89dcf98dc695b |
---|---|
record_format |
Article |
spelling |
doaj-7ea3d5866df04bde97a89dcf98dc695b2020-11-24T20:52:28ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882013-01-01201310.1155/2013/928129928129Efficacy of Contact Needle Therapy for Chemotherapy-Induced Peripheral NeuropathyKeiko Ogawa0Masao Ogawa1Koji Nishijima2Masaki Tsuda3Genichi Nishimura4Department of Otorhinolaryngology and Head and Neck Surgery, Clinic of Japanese Oriental (Kampo) Medicine, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa-City, Ishikawa 920-8641, JapanDepartment of Anesthesiology, Kanazawa Medical University Hospital, 1-1, Daigaku, Uchinada, Kahoku-gun, Ishikawa 920-0265, JapanDepartment of Surgery, Japanese Red Cross Kanazawa Hospital, Mima 2-251, Kanazawa 921-8162, JapanMukeido Acupuncture and Moxibustion Office, Niku 126-7, Horikawa, Koizumi-cho, Toyama 939-8081, JapanDepartment of Surgery, Japanese Red Cross Kanazawa Hospital, Mima 2-251, Kanazawa 921-8162, JapanCancer chemotherapy-induced peripheral neuropathy (CIPN) often results in discontinuation of treatment with potentially useful anticancer drugs and may deteriorate the patient’s quality of life. This study investigated the effect of contact needle therapy (CNT) on CIPN caused by responsible chemotherapeutic agents as taxanes and oxaliplatin. Six patients with CIPN were treated with CNT. The severity of CIPN was evaluated using the Common Terminology Criteria for Adverse Events (CTCAE) version 4 and FACT/GOG-Ntx before and after CNT. After the treatment, all of the patients showed some improvement. Four patients showed apparent improvement in breakthrough pain. One of the cases had difficulty in walking because of CIPN in lower extremities, but after 2 times of CNT, he could walk without pain and could continue the chemotherapy. Although its putative mechanisms remain elusive, CNT has strong potential as an adjunctive therapy in CIPN. Well-designed clinical trials with adequate sample size and power are necessary to confirm the findings of this study.http://dx.doi.org/10.1155/2013/928129 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Keiko Ogawa Masao Ogawa Koji Nishijima Masaki Tsuda Genichi Nishimura |
spellingShingle |
Keiko Ogawa Masao Ogawa Koji Nishijima Masaki Tsuda Genichi Nishimura Efficacy of Contact Needle Therapy for Chemotherapy-Induced Peripheral Neuropathy Evidence-Based Complementary and Alternative Medicine |
author_facet |
Keiko Ogawa Masao Ogawa Koji Nishijima Masaki Tsuda Genichi Nishimura |
author_sort |
Keiko Ogawa |
title |
Efficacy of Contact Needle Therapy for Chemotherapy-Induced Peripheral Neuropathy |
title_short |
Efficacy of Contact Needle Therapy for Chemotherapy-Induced Peripheral Neuropathy |
title_full |
Efficacy of Contact Needle Therapy for Chemotherapy-Induced Peripheral Neuropathy |
title_fullStr |
Efficacy of Contact Needle Therapy for Chemotherapy-Induced Peripheral Neuropathy |
title_full_unstemmed |
Efficacy of Contact Needle Therapy for Chemotherapy-Induced Peripheral Neuropathy |
title_sort |
efficacy of contact needle therapy for chemotherapy-induced peripheral neuropathy |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-427X 1741-4288 |
publishDate |
2013-01-01 |
description |
Cancer chemotherapy-induced peripheral neuropathy (CIPN) often results in discontinuation of treatment with potentially useful anticancer drugs and may deteriorate the patient’s quality of life. This study investigated the effect of contact needle therapy (CNT) on CIPN caused by responsible chemotherapeutic agents as taxanes and oxaliplatin. Six patients with CIPN were treated with CNT. The severity of CIPN was evaluated using the Common Terminology Criteria for Adverse Events (CTCAE) version 4 and FACT/GOG-Ntx before and after CNT. After the treatment, all of the patients showed some improvement. Four patients showed apparent improvement in breakthrough pain. One of the cases had difficulty in walking because of CIPN in lower extremities, but after 2 times of CNT, he could walk without pain and could continue the chemotherapy. Although its putative mechanisms remain elusive, CNT has strong potential as an adjunctive therapy in CIPN. Well-designed clinical trials with adequate sample size and power are necessary to confirm the findings of this study. |
url |
http://dx.doi.org/10.1155/2013/928129 |
work_keys_str_mv |
AT keikoogawa efficacyofcontactneedletherapyforchemotherapyinducedperipheralneuropathy AT masaoogawa efficacyofcontactneedletherapyforchemotherapyinducedperipheralneuropathy AT kojinishijima efficacyofcontactneedletherapyforchemotherapyinducedperipheralneuropathy AT masakitsuda efficacyofcontactneedletherapyforchemotherapyinducedperipheralneuropathy AT genichinishimura efficacyofcontactneedletherapyforchemotherapyinducedperipheralneuropathy |
_version_ |
1716799564175900672 |